These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29547053)

  • 1. Explorative Investigation of Whole-Lesion Histogram MRI Metrics for Differentiating Uterine Leiomyomas and Leiomyosarcomas.
    Gerges L; Popiolek D; Rosenkrantz AB
    AJR Am J Roentgenol; 2018 May; 210(5):1172-1177. PubMed ID: 29547053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory Study of Apparent Diffusion Coefficient Histogram Metrics in Assessing Pancreatic Malignancy.
    Taffel MT; Luk L; Ream JM; Rosenkrantz AB
    Can Assoc Radiol J; 2019 Nov; 70(4):416-423. PubMed ID: 31604596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
    Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
    Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas.
    Al Khuri M; Al Salmi I; Al Ajmi H; Al Hadidi A; Alabousi A; Haider E; Vasudev P; Al Salmi A; Jose S; Alrahbi N
    Int J Gynecol Cancer; 2024 Jul; 34(7):1027-1033. PubMed ID: 38658016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
    Rio G; Lima M; Gil R; Horta M; Cunha TM
    Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
    Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
    J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine smooth muscle tumours with hyperintense area on T
    Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
    Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants.
    Bura V; Pintican RM; David RE; Addley HC; Smith J; Jimenez-Linan M; Lee J; Freeman S; Georgiu C
    Br J Radiol; 2021 Sep; 94(1125):20210283. PubMed ID: 34289327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
    Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
    AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
    Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
    Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle tumours of the uterus: MR imaging malignant predictive features-a 12-year analysis in a referral hospital in Portugal.
    Freitas P; Resende-Neves T; Lameira P; Costa M; Dias P; Filipe J; Ferreira J; Félix A; Cunha TM
    Arch Gynecol Obstet; 2024 Apr; 309(4):1551-1560. PubMed ID: 38055011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
    Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
    Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
    Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of Ultrasound, Contrast-enhanced CT, and Conventional MRI for Differentiating Leiomyoma From Leiomyosarcoma.
    Gaetke-Udager K; McLean K; Sciallis AP; Alves T; Maturen KE; Mervak BM; Moore AG; Wasnik AP; Erba J; Davenport MS
    Acad Radiol; 2016 Oct; 23(10):1290-7. PubMed ID: 27396800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
    Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
    Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging.
    Sun S; Bonaffini PA; Nougaret S; Fournier L; Dohan A; Chong J; Smith J; Addley H; Reinhold C
    Diagn Interv Imaging; 2019 Oct; 100(10):619-634. PubMed ID: 31427216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.